Sebec, ME, United States of America

Michael Kagan

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Quanterix Corporation, Janssen Diagnostics, LLC. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Kagan. Retrieved from https://idiyas.com/inventor/michael-kagan-m29l3vfl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Michael Kagan: Innovator in Ultra-Sensitive Detection Systems**

Introduction

Michael Kagan is an accomplished inventor based in Sebec, Maine, known for his significant contributions to the field of molecular detection. With a total of four patents to his name, Kagan has developed innovative systems that enhance the sensitivity and efficiency of assays designed to detect and measure analyte molecules or particles in various fluid samples.

Latest Patents

Kagan's latest patents focus on systems, devices, and methods for ultra-sensitive detection of molecules or particles. These patents describe advanced technologies related to various aspects of assays, aimed at accurately determining the concentration of specific analyte molecules or particles within a sample fluid. Notably, these systems often utilize assay consumables that feature multiple assay sites. Automation is a key aspect of these inventions, with features that include the insertion of numerous beads into assay sites, sealing those sites, and imaging them to ensure precise measurements.

Career Highlights

Throughout his career, Michael Kagan has worked with notable companies, including Quanterix Corporation and Janssen Diagnostics, LLC. His roles at these organizations have greatly contributed to the advancement of diagnostic technologies, particularly in the realm of ultra-sensitive detection methods.

Collaborations

Kagan has collaborated with a variety of talented individuals, including David Fournier and Todd Campbell. These partnerships have allowed for the exchange of ideas and helped foster innovative solutions in the detection industry, driving forward the capabilities of molecular diagnostics.

Conclusion

Michael Kagan’s work exemplifies how targeted innovation in detection systems can lead to remarkable advancements in scientific research and medical diagnostics. With a focus on automation and sensitivity, his inventions hold the potential to significantly impact the detection of critical analytes, paving the way for future breakthroughs in diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…